Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Nektar Therapeutics Inc. (NKTR)

NASDAQ: Health Care

Get a 5-page Ratings Report on (NKTR) now
$9.57 -0.16 | -1.64%
Today's Range: 9.55 - 9.80
NKTR Avg. Daily Volume: 903,400
05/22/13 - 12:40 PM ET
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: -6.03
  • Price Earnings Comparisons:
    NKTR Sector Avg. S&P 500
    -6.03 0.00 17.70
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    8.31% 51.79% -19.92%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 13.60 0.13 0.04
    Net Income 0.00 0.00 0.00
    EPS 0.00 0.35 0.00
  • Earnings for NKTR:
    EBITDA -125,018,000
    REVENUE 81,191,000
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $-0.44 $0.23 $-1.02 $-0.71
Number of Analysts 6 5 7 6
High Estimate $-0.38 $0.34 $-0.91 $-0.09
Low Estimate $-0.49 $0.14 $-1.21 $-1.70
Prior Year $-0.30 $-0.38 $-1.49 $-1.02
Growth Rate (Year over Year) -46.11% 159.47% 31.45% 30.33%
(NKTR) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,466.90 79.32 0.52%
NASDAQ 3,511.42 9.30 0.27%
S&P 500 1,677.21 8.05 0.48%
US 10 Yr 2.021% +0.077

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs